Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up

Activation and expansion are essential for success in both autologous and allogeneic therapies.

Development of Gamma-Delta T-Cell Therapies

Continuous manufacturing and a quality-by-design development approach are a natural fit.

QbD for Small-Molecule Continuous Process Development

Topic

Articles

Recent trends in dissolution testing have led to increased use of data integrity solutions and more biorelevant testing techniques.

Advances in Dissolution Testing

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Partnering with an experienced service provider can help companies unlock the commercial potential of new therapeutic approaches.

Unlocking Formulation Expertise

Thermo Fisher Scientific has expanded its state-of-the-art R&D facility in Hyderabad, India.

Thermo Fisher Scientific Expands R&D Facility in Hyderabad

GeoVax has received a patent for its malaria vaccine from the US Patent and Trademark Office.

USPTO Issues Malaria Vaccine Patent to GeoVax

Johnson & Johnson has launched its next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town.

Johnson & Johnson Launches Next Satellite Center for Global Health Discovery

The European Investment Bank has provided €15 million to fund coronavirus research at IRBM.

EIB Provides €15 million to IRBM

Otsuka Pharmaceutical and Osaka University have entered an exclusive license agreement on a new anti-tumor antibody.

Otsuka Pharmaceutical and Osaka University Enter Exclusive License Agreement 

Meg Rivers is the former senior editor for 

Podcasts

In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, interviews Joy Aho, senior product manager at Be The Match BioTherapies, about sourcing autologous and allogeneic cell therapies.

Drug Solutions Podcast: Sourcing Autologous and Allogeneic Cell Therapies

AmoyDX has entered a Master Collaboration Agreement with AstraZeneca for multiple companion diagnostics programs in China, EU, and Japan.

AmoyDX and AstraZeneca Enter Master Collaboration Agreement

ReiThera and Exothera are collaborating to develop a large-scale, low-cost-per-dose manufacturing process to deliver novel vaccines to low and middle-income countries.

Drug Development

Research into Cold Cancers Heating Up

Development of Gamma-Delta T-Cell Therapies

QbD for Small-Molecule Continuous Process Development